SS
Elite in Migraine

Dr. Stephen D. Silberstein

Philadelphia Office
Philadelphia, PA
Elite
 in Migraine
Specialties:Neurology
Experience:60 Years
Accepts:New PatientsMedicare
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Stephen D. Silberstein's experience treating your condition:
About Dr. Stephen D. Silberstein

Stephen Silberstein is a Neurologist in Philadelphia, Pennsylvania. Silberstein has been practicing medicine for over 60 years and is rated as an Elite expert by MediFind in the treatment of Migraine. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Migraine, Headache, Cluster Headache, and Migraine with Brainstem Aura. He is licensed to treat patients in Pennsylvania. Silberstein is currently accepting new patients.

His clinical research consists of co-authoring 247 peer reviewed articles and participating in 19 clinical trials in the past 15 years. In particular, he has co-authored 221 articles and participated in 17 clinical trials in the study of Migraine.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Stephen D. Silberstein it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
900 Walnut St, Suite 200, Philadelphia, PA 19107
Background & Education
Graduate Institution
Perelman School Of Med At The University Of Pennsylvania, 1963
Specialties
Neurology
Licenses
Psychiatry & Neurology in PA
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials
NINDS Clinical Research Collaboration Chronic Migraine Treatment Trial
Enrollment Status: Completed
Publish Date: January 24, 2012
Intervention Type: Drug
Study Phase: Phase 3
Comparison Of Greater Occipital Nerve Block With Lidocaine And Bupivicaine Alone Or With Steroids In a Chronic Headache Population
Enrollment Status: Completed
Publish Date: May 07, 2014
Intervention Type: Drug
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Add-on Therapy Study of Xeomin (Incobotulinumtoxina) Versus Placebo in the Treatment of Trigeminal Neuralgia
Enrollment Status: Terminated
Publish Date: December 13, 2021
Intervention Type: Biological, Other
Study Phase: Phase 2
A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
Enrollment Status: Terminated
Publish Date: June 19, 2019
Intervention Type: Device
Study Phase: Not Applicable
Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?
Enrollment Status: Completed
Publish Date: January 07, 2011
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.
Enrollment Status: Terminated
Publish Date: August 25, 2011
Intervention Type: Drug
Study Phase: Not Applicable
An Open-Label Pilot Trial To Collect And Evaluate Data On The Use Of Migranal® In The Treatment Of Two Acute Migraine Attacks Associated With Cutaneous Allodynia
Enrollment Status: Completed
Publish Date: March 11, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache
Enrollment Status: Completed
Publish Date: May 26, 2011
Intervention Type: Drug
Study Phase: Not Applicable
A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine.
Enrollment Status: Completed
Publish Date: December 03, 2012
Intervention Type: Drug
Study Phase: Phase 2
An Open Label Pilot Trial to Collect and Evaluate Data on the Use of Dihydroergotamine Mesylate in the Treatment of Two Migraine Attacks Associated With Cutaneous Allodynia
Enrollment Status: Completed
Publish Date: June 09, 2014
Intervention Type: Drug
Study Phase: Not Applicable
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache
Enrollment Status: Completed
Publish Date: September 09, 2019
Intervention Type: Drug
Study Phase: Phase 3
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Drug
Study Drugs: ErenumabOral Prophylactic
Study Phase: Phase 4
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Enrollment Status: Completed
Publish Date: July 30, 2020
Intervention Type: Device, Other
Study Phase: Not Applicable
An Open-Label, Pilot Study Examining the Use of Soy Isoflavones in the Prevention of Menstrually-Associated Migraine
Enrollment Status: Completed
Publish Date: January 23, 2009
Intervention Type: Drug
Study Phase: Not Applicable
An Open-label Pilot Study to Collect/Evaluate Data on the Use of Consecutive Daily Intravenous Doses of Depacon in Combination With Daily Dose of Depakote ER During a Cluster Headache Cycle.
Enrollment Status: Completed
Publish Date: July 15, 2011
Intervention Type: Drug
Study Phase: Not Applicable
A Double-blind, Placebo-controlled Pilot Study to Collect and Evaluate Data on the Use of Intravenous Ibuprofen in the Treatment of an Acute Migraine Attack
Enrollment Status: Completed
Publish Date: September 06, 2022
Intervention Type: Other, Drug
Study Drug: Ibuprofen
Study Phase: Phase 4
A Study to Evaluate the Efficacy and Tolerability of STOPAIN in the Treatment of a Single Migraine Attack
Enrollment Status: Completed
Publish Date: June 09, 2017
Intervention Type: Drug
Study Phase: Not Applicable
View 18 Less Clinical Trials -
249 Total Publications
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition.
Journal: Cephalalgia : an international journal of headache
Published: May 06, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
WY
Dr. William B. Young
Neurology
Elite
Highly rated in
9
conditions
Neurology

Jefferson Health

Philadelphia Office

900 Walnut St, 
Philadelphia, PA 

William Young is a Neurologist in Philadelphia, Pennsylvania. Young has been practicing medicine for over 38 years and is rated as a Distinguished expert by MediFind in the treatment of Migraine. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Migraine, New Daily Persistent Headache (NDPH), Migraine with Brainstem Aura, and Headache. He is licensed to treat patients in Pennsylvania. Young is currently accepting new patients.

MM
Dr. Michael J. Marmura
Neurology
Elite
Highly rated in
10
conditions
Neurology

Jefferson Health

Philadelphia Office

900 Walnut St, 
Philadelphia, PA 

Michael Marmura is a Neurologist in Philadelphia, Pennsylvania. Marmura has been practicing medicine for over 21 years and is rated as a Distinguished expert by MediFind in the treatment of Migraine. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Migraine, New Daily Persistent Headache (NDPH), Headache, and Cluster Headache. He is licensed to treat patients in Pennsylvania. Marmura is currently accepting new patients.

CL
Dr. Clinton G. Lauritsen
Neurology
Distinguished
Highly rated in
2
conditions
Neurology

Jefferson Health

Jefferson Hospital For Neuroscience

900 Walnut St, 
Philadelphia, PA 
 0.1 mi

Clinton Lauritsen is a Neurologist in Philadelphia, Pennsylvania. Lauritsen has been practicing medicine for over 11 years and is rated as an Advanced expert by MediFind in the treatment of Migraine. He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Migraine, Headache, Cluster Headache, Migraine with Brainstem Aura, and Hormone Replacement Therapy (HRT). He is licensed to treat patients in Pennsylvania. Lauritsen is currently accepting new patients.